The landscape of global health is complex and constantly evolving, presenting immense challenges in resource allocation, ...

By Diederik StadigUS President Donald Trump signed a new executive order on 15 April aimed at bringing US drug prices down.

The pharmaceutical sector has been making headlines for large-scale layoffs, department closures and clinical trial failures.

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

At the same time, drugmakers have come to rely on the U.S. market for the bulk of their revenue. In 2022, the U.S. accounted ...

The price of pharmaceuticals will likely go up soon, and generics are poised to be hit the hardest.

Denise Bronner, Ph.D., makes the case for and against acquisitions for rejuvenating Big Pharma pipelines. She explains why ...

As we’ve been reporting, US Vice-President JD Vance says there is a “good chance” that the US and UK will come to a mutually ...

MSD obtains a Non-Exclusive License for Cyprumed’s delivery technology to develop oral peptide therapeuticsCyprumed will be ...

The moves, announced Monday in the Federal Register, are a precursor to imposing tariffs and threaten to broaden the president’s sweeping US trade war ...

Additionally, some employees in the 50-55 age bracket, primarily within the research and development division, have been ...

A report claimed that employees in the age group of 50-55 years working in Dr Reddy’s research and development (R&D) division ...